Sensitive non-invasive technology developed to detect changes in protein biomarkers associated with TBI

Neurons and Synapses

From NYU Langone Medical Center:

Enhancing Studies on a Possible Blood Biomarker for Traumatic Brain Injury

NYU Langone Medical Center Introducing New Technology to Identify Head Injuries at Earliest Possible Stages

February 27, 2015 (9:00AM)

New technology being introduced at NYU Langone Medical Center could help researchers advance blood biomarker capabilities that show changes in low concentrations of specific proteins present following a neurological injury.

The single molecule array (Simoa) technology developed by Quanterix, and the fully automated HD-1 analyzer, offers unprecedented improvement in sensitivity proteins over current technologies for the detection of blood-based biomarkers – as much as 1000 times more sensitive than conventional immunoassays. Specifically, it allows for more effective measurement of low concentration of proteins such as tau, a normal protein that is released from brain cells following a brain injury.

The single molecule array (Simoa) technology developed by Quanterix, and the fully automated HD-1 analyzer.

Utilizing…

View original post 651 more words

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s